|
1
|
Manolova Y, Deneva V, Antonov L, Drakalska
E, Momekova D and Lambov N: The effect of the water on the curcumin
tautomerism: A quantitative approach. Spectrochim Acta A Mol Biomol
Spectrosc. 132:815–820. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fu S, Shen Z, Ajlouni S, Ng K, Sanguansri
L and Augustin MA: Interactions of buttermilk with curcuminoids.
Food Chem. 149:47–53. 2014. View Article : Google Scholar
|
|
3
|
Gostner J, Ciardi C, Becker K, Fuchs D and
Sucher R: Immunoregulatory impact of food antioxidants. Curr Pharm
Des. 20:840–849. 2014. View Article : Google Scholar
|
|
4
|
Gupta SC, Kismali G and Aggarwal BB:
Curcumin, a component of turmeric: From farm to pharmacy.
Biofactors. 39:2–13. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maruta H: Herbal therapeutics that block
the oncogenic kinase PAK1: A practical approach towards
PAK1-dependent diseases and longevity. Phytother Res. 28:656–672.
2014. View
Article : Google Scholar
|
|
6
|
Srinivasan K: Antioxidant potential of
spices and their active constituents. Crit Rev Food Sci Nutr.
54:352–372. 2014. View Article : Google Scholar
|
|
7
|
Current clinical trials on curcumin. US
National Institutes of Health, Clinical Trial Registry; June. 2015.
2015
|
|
8
|
Bar-Sela G, Epelbaum R and Schaffer M:
Curcumin as an anticancer agent: Review of the gap between basic
and clinical applications. Curr Med Chem. 17:190–197. 2010.
View Article : Google Scholar
|
|
9
|
Chainani-Wu N: Safety and
anti-inflammatory activity of curcumin: A component of tumeric
(Curcuma longa). J Altern Complement Med. 9:161–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goel A, Kunnumakkara AB and Aggarwal BB:
Curcumin as 'Curecumin': From kitchen to clinic. Biochem Pharmacol.
75:787–809. 2008. View Article : Google Scholar
|
|
11
|
Dhillon N, Aggarwal BB, Newman RA, Wolff
RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V and Kurzrock
R: Phase II trial of curcumin in patients with advanced pancreatic
cancer. Clin Cancer Res. 14:4491–4499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen L and Ji HF: Contribution of
degradation products to the anticancer activity of curcumin. Clin
Cancer Res. 15:7108author reply 7108–7109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS,
Hsieh CY and Lin JK: Stability of curcumin in buffer solutions and
characterization of its degradation products. J Pharm Biomed Anal.
15:1867–1876. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tønnesen HH: Solubility, chemical and
photochemical stability of curcumin in surfactant solutions.
Studies of curcumin and curcuminoids, XXVIII. Pharmazie.
57:820–824. 2002.
|
|
15
|
Schneider C, Gordon ON, Edwards RL and
Luis PB: Degradation of Curcumin: From Mechanism to Biological
Implications. J Agric Food Chem. 63:7606–7614. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Metzler M, Pfeiffer E, Schulz SI and Dempe
JS: Curcumin uptake and metabolism. Biofactors. 39:14–20. 2013.
View Article : Google Scholar
|
|
17
|
Mohanty C and Sahoo SK: The in vitro
stability and in vivo pharmacokinetics of curcumin prepared as an
aqueous nanoparticulate formulation. Biomaterials. 31:6597–6611.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tønnesen HH and Karlsen J: Studies on
curcumin and curcuminoids. VI Kinetics of curcumin degradation in
aqueous solution. Z Lebensm Unters Forsch. 180:402–404. 1985.
View Article : Google Scholar
|
|
19
|
Priyadarsini KI: The chemistry of
curcumin: From extraction to therapeutic agent. Molecules.
19:20091–20112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Agrawal DK and Mishra PK: Curcumin and its
analogues: Potential anticancer agents. Med Res Rev. 30:818–860.
2010.
|
|
21
|
Mazumder A, Neamati N, Sunder S, Schulz J,
Pertz H, Eich E and Pommier Y: Curcumin analogs with altered
potencies against HIV-1 integrase as probes for biochemical
mechanisms of drug action. J Med Chem. 40:3057–3063. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jayaprakasam B, Vanisree M, Zhang Y,
Dewitt DL and Nair MG: Impact of alkyl esters of caffeic and
ferulic acids on tumor cell proliferation, cyclooxygenase enzyme,
and lipid peroxidation. J Agric Food Chem. 54:5375–5381. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jung KJ, Go EK, Kim JY, Yu BP and Chung
HY: Suppression of age-related renal changes in NF-kappaB and its
target gene expression by dietary ferulate. J Nutr Biochem.
20:378–388. 2009. View Article : Google Scholar
|
|
24
|
Murakami Y, Hirata A, Ito S, Shoji M,
Tanaka S, Yasui T, Machino M and Fujisawa S: Re-evaluation of
cyclooxygenase-2-inhibiting activity of vanillin and guaiacol in
macrophages stimulated with lipopolysaccharide. Anticancer Res.
27:801–807. 2007.PubMed/NCBI
|
|
25
|
Chang YC, Lee FW, Chen CS, Huang ST, Tsai
SH, Huang SH and Lin CM: Structure-activity relationship of C6-C3
phenylpropanoids on xanthine oxidase-inhibiting and free
radical-scavenging activities. Free Radic Biol Med. 43:1541–1551.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen L and Ji HF: Insights into the
inhibition of xanthine oxidase by curcumin. Bioorg Med Chem Lett.
19:5990–5993. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gordon ON and Schneider C: Vanillin and
ferulic acid: Not the major degradation products of curcumin.
Trends Mol Med. 18:361–363; author reply 363–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gordon ON, Luis PB, Ashley RE, Osheroff N
and Schneider C: Oxidative transformation of demethoxy- and
bisdemethoxycurcumin: Products, mechanism of formation, and
poisoning of human topoisomerase IIα. Chem Res Toxicol. 28:989–996.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Griesser M, Pistis V, Suzuki T, Tejera N,
Pratt DA and Schneider C: Autoxidative and cyclooxygenase-2
catalyzed transformation of the dietary chemopreventive agent
curcumin. J Biol Chem. 286:1114–1124. 2011. View Article : Google Scholar :
|
|
30
|
Ketron AC, Gordon ON, Schneider C and
Osheroff N: Oxidative metabolites of curcumin poison human type II
topoisomerases. Biochemistry. 52:221–227. 2013. View Article : Google Scholar :
|
|
31
|
Ansari MJ, Ahmad S, Kohli K, Ali J and
Khar RK: Stability-indicating HPTLC determination of curcumin in
bulk drug and pharmaceutical formulations. J Pharm Biomed Anal.
39:132–138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Heger M, van Golen RF, Broekgaarden M and
Michel MC: The molecular basis for the pharmacokinetics and
pharmacodynamics of curcumin and its metabolites in relation to
cancer. Pharmacol Rev. 66:222–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tønnesen HH, de Vries H, Karlsen J and
Beijersbergen van Henegouwen G: Studies on curcumin and
curcuminoids. IX: Investigation of the photobiological activity of
curcumin using bacterial indicator systems. J Pharm Sci.
76:371–373. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tønnesen HH, Karlsen J and van Henegouwen
GB: Studies on curcumin and curcuminoids. VIII Photochemical
stability of curcumin. Z Lebensm Unters Forsch. 183:116–122. 1986.
View Article : Google Scholar
|
|
35
|
Galer P and Šket B: Photodegradation of
methoxy substituted curcuminoids. Acta Chim Slov. 62:346–353. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Leite DP, Paolillo FR, Parmesano TN,
Fontana CR and Bagnato VS: Effects of photodynamic therapy with
blue light and curcumin as mouth rinse for oral disinfection: A
randomized controlled trial. Photomed Laser Surg. 32:627–632. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mahdi Z, Habiboallh G, Mahbobeh NN, Mina
ZJ, Majid Z and Nooshin A: Lethal effect of blue light-activated
hydrogen peroxide, curcumin and erythrosine as potential oral
photosensitizers on the viability of Porphyromonas gingivalis and
Fusobacterium nucleatum. Laser Ther. 24:103–111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yin R and Hamblin MR: Antimicrobial
photosensitizers: Drug discovery under the spotlight. Curr Med
Chem. 22:2159–2185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Skrzypczak-Jankun E, Zhou K, McCabe NP,
Selman SH and Jankun J: Structure of curcumin in complex with
lipoxygenase and its significance in cancer. Int J Mol Med.
12:17–24. 2003.PubMed/NCBI
|
|
40
|
Jankun J, Doerks T, Aleem AM,
Lysiak-Szydłowska W and Skrzypczak-Jankun E: Do human lipoxygenases
have a PDZ regulatory domain? Curr Mol Med. 8:768–773. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ji HF and Zhang HY: Multipotent natural
agents to combat Alzheimer's disease. Functional spectrum and
structural features. Acta Pharmacol Sin. 29:143–151. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang HY: One-compound-multiple-targets
strategy to combat Alzheimer's disease. FEBS Lett. 579:5260–5264.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Barik A, Mishra B, Kunwar A, Kadam RM,
Shen L, Dutta S, Padhye S, Satpati AK, Zhang HY and Indira
Priyadarsini K: Comparative study of copper(II)-curcumin complexes
as superoxide dismutase mimics and free radical scavengers. Eur J
Med Chem. 42:431–439. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Barik A, Mishra B, Shen L, Mohan H, Kadam
RM, Dutta S, Zhang HY and Priyadarsini KI: Evaluation of a new
copper(II)-curcumin complex as superoxide dismutase mimic and its
free radical reactions. Free Radic Biol Med. 39:811–822. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Eybl V, Kotyzová D, Lesetický L, Bludovská
M and Koutenský J: The influence of curcumin and manganese complex
of curcumin on cadmium-induced oxidative damage and trace elements
status in tissues of mice. J Appl Toxicol. 26:207–212. 2006.
View Article : Google Scholar
|
|
46
|
Fouladvand M, Barazesh A and Tahmasebi R:
Evaluation of in vitro antileishmanial activity of curcumin and its
derivatives 'gallium curcumin, indium curcumin and diacethyle
curcumin'. Eur Rev Med Pharmacol Sci. 17:3306–3308. 2013.
|
|
47
|
Gaurav C, Goutam R, Rohan KN, Sweta KT,
Abhay CS and Amit GK: (Copper-curcumin) beta-cyclodextrin vaginal
gel: delivering a novel metal-herbal approach for the development
of topical contraception prophylaxis. Eur J Pharm Sci. 65:183–191.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hatcher H, Planalp R, Cho J, Torti FM and
Torti SV: Curcumin: From ancient medicine to current clinical
trials. Cell Mol Life Sci. 65:1631–1652. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
John VD, Kuttan G and Krishnankutty K:
Anti-tumour studies of metal chelates of synthetic curcuminoids. J
Exp Clin Cancer Res. 21:219–224. 2002.PubMed/NCBI
|
|
50
|
Zebib B, Mouloungui Z and Noirot V:
Stabilization of curcumin by complexation with divalent cations in
glycerol/water system. Bioinorg Chem Appl. 2010:2927602010.
View Article : Google Scholar :
|
|
51
|
Mei X, Xu D and Xu S, Zheng Y and Xu S:
Gastroprotective and antidepressant effects of a new
zinc(II)-curcumin complex in rodent models of gastric ulcer and
depression induced by stresses. Pharmacol Biochem Behav. 99:66–74.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yu C, Mei XT, Zheng YP and Xu DH:
Zn(II)-curcumin protects against hemorheological alterations,
oxidative stress and liver injury in a rat model of acute
alcoholism. Environ Toxicol Pharmacol. 37:729–737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Refat MS: Synthesis and characterization
of ligational behavior of curcumin drug towards some transition
metal ions: Chelation effect on their thermal stability and
biological activity. Spectrochim Acta A Mol Biomol Spectrosc.
105:326–337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Barik A, Priyadarsini KI and Mohan H:
Photophysical studies on binding of curcumin to bovine serum
albumins. Photochem Photobiol. 77:597–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wootton LL and Michelangeli F: The effects
of the phenylalanine 256 to valine mutation on the sensitivity of
sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA)
Ca2+ pump isoforms 1, 2, and 3 to thapsigargin and other
inhibitors. J Biol Chem. 281:6970–6976. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Logan-Smith MJ, Lockyer PJ, East JM and
Lee AG: Curcumin, a molecule that inhibits the
Ca2+-ATPase of sarcoplasmic reticulum but increases the
rate of accumulation of Ca2+. J Biol Chem.
276:46905–46911. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hasmeda M and Polya GM: Inhibition of
cyclic AMP-dependent protein kinase by curcumin. Phytochemistry.
42:599–605. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jung KT and Lim KJ: Curcumin, COX-2, and
Protein p300/CBP. Korean J Pain. 27:365–366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bukhari SN, Lauro G, Jantan I, Bifulco G
and Amjad MW: Pharmacological evaluation and docking studies of
α,β-unsaturated carbonyl based synthetic compounds as inhibitors of
secretory phospholipase A2, cyclooxygenases,
lipoxygenase and proinflammatory cytokines. Bioorg Med Chem.
22:4151–4161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Skrzypczak-Jankun E, McCabe NP, Selman SH
and Jankun J: Curcumin inhibits lipoxygenase by binding to its
central cavity: Theoretical and X-ray evidence. Int J Mol Med.
6:521–526. 2000.PubMed/NCBI
|
|
61
|
Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang
S, Lee MJ and Yang CS: Modulation of arachidonic acid metabolism by
curcumin and related beta-diketone derivatives: Effects on
cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxy-genase.
Carcinogenesis. 25:1671–1679. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Heng MC: Signaling pathways targeted by
curcumin in acute and chronic injury: Burns and photo-damaged skin.
Int J Dermatol. 52:531–543. 2013. View Article : Google Scholar
|
|
63
|
Reddy S and Aggarwal BB: Curcumin is a
non-competitive and selective inhibitor of phosphorylase kinase.
FEBS Lett. 341:19–22. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Manikandan P, Sumitra M, Aishwarya S,
Manohar BM, Lokanadam B and Puvanakrishnan R: Curcumin modulates
free radical quenching in myocardial ischaemia in rats. Int J
Biochem Cell Biol. 36:1967–1980. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lin JK and Shih CA: Inhibitory effect of
curcumin on xanthine dehydrogenase/oxidase induced by
phorbol-12-myristate-13-acetate in NIH3T3 cells. Carcinogenesis.
15:1717–1721. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Aggarwal BB, Surh J and Shishodia S: The
Molecular Targets and Therapeutic Uses of Curcumin in Health and
Disease. Springer; New York, NY: 2007, View Article : Google Scholar
|
|
67
|
Asai A and Miyazawa T: Occurrence of
orally administered curcuminoid as glucuronide and
glucuronide/sulfate conjugates in rat plasma. Life Sci.
67:2785–2793. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Holder GM, Plummer JL and Ryan AJ: The
metabolism and excretion of curcumin
(1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in
the rat. Xenobiotica; the fate of foreign compounds in biological
systems. 8:761–768. 1978. View Article : Google Scholar
|
|
69
|
Wahlström B and Blennow G: A study on the
fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh).
43:86–92. 1978. View Article : Google Scholar
|
|
70
|
Anand P, Kunnumakkara AB, Newman RA and
Aggarwal BB: Bioavailability of curcumin: Problems and promises.
Mol Pharm. 4:807–818. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Garcea G, Jones DJ, Singh R, Dennison AR,
Farmer PB, Sharma RA, Steward WP, Gescher AJ and Berry DP:
Detection of curcumin and its metabolites in hepatic tissue and
portal blood of patients following oral administration. Br J
Cancer. 90:1011–1015. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ,
Moon DO, Lee CM, Ahn SC, Park YC and Park YM: Curcumin inhibits
immunostimulatory function of dendritic cells: MAPKs and
translocation of NF-kappa B as potential targets. J Immunol.
174:8116–8124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Mun SH, Kim HS, Kim JW, Ko NY, Kim K, Lee
BY, Kim B, Won HS, Shin HS, Han JW, et al: Oral administration of
curcumin suppresses production of matrix metalloproteinase (MMP)-1
and MMP-3 to ameliorate collagen-induced arthritis: Inhibition of
the PKCdelta/JNK/c-Jun pathway. J Pharmacol Sci. 111:13–21. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kirkwood KL, Cirelli JA, Rogers JE and
Giannobile WV: Novel host response therapeutic approaches to treat
periodontal diseases. Periodontol 2000. 43:294–315. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Mahakunakorn P, Tohda M, Murakami Y,
Matsumoto K, Watanabe H and Vajaragupta O: Cytoprotective and
cytotoxic effects of curcumin: Dual action on H2O2-induced
oxidative cell damage in NG108-15 cells. Biol Pharm Bull.
26:725–728. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Guimarães MR, Coimbra LS, de Aquino SG,
Spolidorio LC, Kirkwood KL and Rossa C Jr: Potent anti-inflammatory
effects of systemically administered curcumin modulate periodontal
disease in vivo. J Periodontal Res. 46:269–279. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Jagetia GC and Rajanikant GK: Curcumin
treatment enhances the repair and regeneration of wounds in mice
exposed to hemibody gamma-irradiation. Plast Reconstr Surg.
115:515–528. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Madhyastha R, Madhyastha H, Nakajima Y,
Omura S and Maruyama M: Curcumin facilitates fibrinolysis and
cellular migration during wound healing by modulating urokinase
plasminogen activator expression. Pathophysiol Haemost Thromb.
37:59–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Oh S, Kyung TW and Choi HS: Curcumin
inhibits osteoclastogenesis by decreasing receptor activator of
nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells.
Mol Cells. 26:486–489. 2008.PubMed/NCBI
|
|
80
|
Singh R, Chandra R, Bose M and Luthra MP:
Antibacterial activity of curcumin longa rhizome extract on
periopathogenic bacteria. Curr Sci. 83:737–740. 2002.
|
|
81
|
Bhatia M, Urolagin SS, Pentyala KB,
Urolagin SB, Menaka KB and Bhoi S: Novel therapeutic approach for
the treatment of periodontitis by curcumin. J Clin Diagn Res.
8:ZC65–ZC69. 2014.
|
|
82
|
Gottumukkala SN, Koneru S, Mannem S and
Mandalapu N: Effectiveness of sub gingival irrigation of an
indigenous 1% curcumin solution on clinical and microbiological
parameters in chronic periodontitis patients: A pilot randomized
clinical trial. Contemp Clin Dent. 4:186–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Khafif A, Schantz SP, Chou TC, Edelstein D
and Sacks PG: Quantitation of chemopreventive synergism between
(−)-epigal-locatechin-3-gallate and curcumin in normal,
premalignant and malignant human oral epithelial cells.
Carcinogenesis. 19:419–424. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Pari L and Murugan P: Tetrahydrocurcumin:
Effect on chloroquine-mediated oxidative damage in rat kidney.
Basic Clin Pharmacol Toxicol. 99:329–334. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Yodkeeree S, Garbisa S and Limtrakul P:
Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via
downregulation of MMPs and uPA. Acta Pharmacol Sin. 29:853–860.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
San Miguel SM, Opperman LA, Allen EP,
Zielinski J and Svoboda KK: Bioactive antioxidant mixtures promote
proliferation and migration on human oral fibroblasts. Arch Oral
Biol. 56:812–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Gu Y, Lee HM, Napolitano N, Clemens M,
Zhang Y, Sorsa T, Zhang Y, Johnson F and Golub LM:
4-methoxycarbonyl curcumin: A unique inhibitor of both inflammatory
mediators and periodontal inflammation. Mediators Inflamm.
2013:3297402013. View Article : Google Scholar
|
|
88
|
Elburki MS, Rossa C, Guimaraes MR,
Goodenough M, Lee HM, Curylofo FA, Zhang Y, Johnson F and Golub LM:
A novel chemically modified curcumin reduces severity of
experimental periodontal disease in rats: Initial observations.
Mediators Inflamm. 2014:9594712014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Shoba G, Joy D, Joseph T, Majeed M,
Rajendran R and Srinivas PS: Influence of piperine on the
pharmacokinetics of curcumin in animals and human volunteers.
Planta Med. 64:353–356. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Mazzarino L, Loch-Neckel G, Bubniak LS,
Mazzucco S, Santos-Silva MC, Borsali R and Lemos-Senna E:
Curcumin-loaded chitosan-coated nanoparticles as a new approach for
the local treatment of oral cavity cancer. J Nanosci Nanotechnol.
15:781–791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Gordon ON, Luis PB, Sintim HO and
Schneider C: Unraveling curcumin degradation: Autoxidation proceeds
through spiroepoxide and vinylether intermediates en route to the
main bicyclopentadione. J Biol Chem. 290:4817–4828. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Kaźmierkiewicz R, Czaplewski C and
Ciarkowski J: Elucidation of neurophysin/bioligand interactions
from molecular modeling. Acta Biochim Pol. 44:453–466. 1997.
|
|
93
|
Zhang YL, Tropsha A, McPhail AT and Lee
KH: Antitumor agents. 152 In vitro inhibitory activity of etoposide
derivative NPF against human tumor cell lines and a study of its
conformation by X-ray crystallography, molecular modeling, and NMR
spectroscopy. J Med Chem. 37:1460–1464. 1994. View Article : Google Scholar : PubMed/NCBI
|
